Direxion Daily S&P Biotec... (LABU)
Direxion Daily S&P Biotech Bull 3X Shares Max Pain By Strike
LABU trades at $70.37, 3.5% above the near-term max pain of $68 expiring Aug 29, 2025 (1 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($60-$215), indicating stable market expectations. Key magnetic zone at 60 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Direxion Daily S&P Biotech Bull 3X Shares Max Pain By Expiry
Max pain for LABU shows stable levels around 84.41, reflecting balanced market expectations. The 184% spread signals divergent expectations across timeframes. Most levels below 70.37 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 29, 2025 | 68 | -2.37 (-3.37%) |
| Sep 5, 2025 | 65 | -5.37 (-7.63%) |
| Sep 12, 2025 | 62 | -8.37 (-11.89%) |
| Sep 19, 2025 | 60 | -10.37 (-14.74%) |
| Sep 26, 2025 | 65 | -5.37 (-7.63%) |
| Oct 3, 2025 | 67.5 | -2.87 (-4.08%) |
| Oct 17, 2025 | 67 | -3.37 (-4.79%) |
| Dec 19, 2025 | 60 | -10.37 (-14.74%) |
| Jan 16, 2026 | 135 | 64.63 (91.84%) |
| Mar 20, 2026 | 64 | -6.37 (-9.05%) |
| Jan 15, 2027 | 215 | 144.63 (205.53%) |